MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors

[1]  A. Vazquez,et al.  MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors , 2012, BMC Biology.

[2]  Zhijian J. Chen,et al.  Role of the Clathrin Terminal Domain in Regulating Coated Pit Dynamics Revealed by Small Molecule Inhibition , 2011, Cell.

[3]  R. Youle,et al.  Regulating mitochondrial outer membrane proteins by ubiquitination and proteasomal degradation. , 2011, Current opinion in cell biology.

[4]  K. Zhao,et al.  Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells. , 2011, The Biochemical journal.

[5]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[6]  A. Vazquez,et al.  Mitochondrial dynamics regulate the RIG‐I‐like receptor antiviral pathway , 2010, EMBO reports.

[7]  Zhijian J. Chen,et al.  Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. , 2009, Molecular cell.

[8]  Qiang Sun,et al.  Ubiquitin-Regulated Recruitment of IκB Kinase ε to the MAVS Interferon Signaling Adapter , 2009, Molecular and Cellular Biology.

[9]  Zhijian J. Chen,et al.  Ubiquitylation in innate and adaptive immunity , 2009, Nature.

[10]  J. Tschopp,et al.  The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases , 2008, Cell Death and Differentiation.

[11]  M. Yoneyama,et al.  Structural mechanism of RNA recognition by the RIG-I-like receptors. , 2008, Immunity.

[12]  Qiang Sun,et al.  The NEMO adaptor bridges the nuclear factor-κB and interferon regulatory factor signaling pathways , 2007, Nature Immunology.

[13]  Osamu Takeuchi,et al.  TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity , 2007, Nature.

[14]  E. Pietras,et al.  Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif , 2006, The EMBO journal.

[15]  D. Garcin,et al.  Sendai virus defective-interfering genomes and the activation of interferon-beta. , 2006, Virology.

[16]  C. Coban,et al.  Essential role of IPS-1 in innate immune responses against RNA viruses , 2006, The Journal of experimental medicine.

[17]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[18]  Hong-Hsing Liu,et al.  The specific and essential role of MAVS in antiviral innate immune responses. , 2006, Immunity.

[19]  A. Shahangian,et al.  Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response , 2006, Nature.

[20]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[21]  Osamu Takeuchi,et al.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.

[22]  Z. Zhai,et al.  VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling , 2005 .

[23]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[24]  Zhijian J. Chen,et al.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. , 2005, Cell.

[25]  Z. Zhai,et al.  VISA is an adapter protein required for virus-triggered IFN-beta signaling. , 2005, Molecular cell.

[26]  BMC Biology , 2004 .

[27]  Satoshi Inoue,et al.  Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth , 2002, Nature.

[28]  Satoshi Inoue,et al.  Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. , 2002, Nature.